Sjögren Syndrome Clinical Trial
— CB-SJOOfficial title:
Prevalence and Characteristics of Dental and Periodontal Lesions in Patients With Sjögren's Syndrome. Establishment of a Biological Saliva Collection.
Sjögren's syndrome (SS) is a rare chronic systemic autoimmune disease characterized by destruction of the exocrine glands, including the salivary glands.The lack of saliva exposes the patient to dental caries, and dental wear although this has rarely been shown in Sjögren's patients. Moreover, these patients seem to have more inflammation and gingival recession, although this has not been clearly identified in the literature. Our main objective is to assess the prevalence of dental wear and gingival recession in patients with Sjögren's syndrome by analyzing of the Basic Erosive Wear Examination (BEWE) score for erosions, Basic Erosive Wear Abrasion (BEWA) score for attrition and percentage of sites with periodontal recessions greater than 3 mm in relation to the total number of sites. Our secondary objectives are to investigate a correlation between the prevalence of dental and gingival wear, gingival inflammation, Decayed, Missing, and Filled Teeth (DMFT) index and (1) salivary parameters and (2) oral quality of life. The salivary samples will be kept in a biological collection within the URP2496 for later analysis (biological collection CB-SJO).
Status | Recruiting |
Enrollment | 90 |
Est. completion date | January 12, 2025 |
Est. primary completion date | January 12, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patient with Sjögren Syndrome - Patient > 18 years old - Patient affiliated to a social security system, beneficiary or beneficiary of a right other than AME - Patient who speaks and understands French well enough to be able to read and understand the study information note. - Patient who does not object to his participation in the study Exclusion Criteria: - Patient having expressed his opposition to participate in the research |
Country | Name | City | State |
---|---|---|---|
France | Service de Médecine bucco-dentaire | Ivry-sur-Seine | Ile De France |
Lead Sponsor | Collaborator |
---|---|
Assistance Publique - Hôpitaux de Paris |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Prevalence of dental wear and gingival recession in patients with Sjögren Syndrome | BEWE score, BEWA score, Percentage of sites with periodontal recessions greater than 3 mm of the total number of sites | 6 months once the collection is completed | |
Secondary | Correlation between the prevalence of dental wear and gingival recession and (1) salivary parameters and (2) oral quality of life | OHIP-14 for the oral quality of life assessment; measure of stimulated and unstimulated flow rate, pH and buffer capacity.; measure of the oral dryness through Xerostomia Inventory | 6 months once the collection is completed | |
Secondary | Correlation between severity of the gingival inflammation and (1) salivary parameters and (2) oral quality of life. | Gingival inflammation assessed using the Bleeding On Probing score | 6 months once the collection is completed | |
Secondary | Correlation between severity of carious disease and (1) salivary parameters and (2) oral quality of life | Carious disease assessed using the DFMT index | 6 months once the collection is completed |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02752269 -
Early Detection of Pulmonary- and Pulmonary Vascular Disease in Sjögren Syndrome
|
||
Completed |
NCT05079581 -
Pelvic Floor Exercises in Patients With Sjögren's
|
N/A | |
Completed |
NCT03905525 -
Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome
|
Phase 2 | |
Completed |
NCT04819269 -
Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome
|
Phase 3 | |
Completed |
NCT02011776 -
A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren Syndrome
|
N/A | |
Recruiting |
NCT06411132 -
Study to Evaluate Corneal Neurosensory Abnormalities in Patients With Sjögren's Dry Eye
|
||
Completed |
NCT03762824 -
Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease
|
Phase 4 | |
Terminated |
NCT04035668 -
A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome
|
Phase 2 | |
Completed |
NCT02049112 -
A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study
|
Phase 4 | |
Completed |
NCT03941184 -
Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity
|
||
Completed |
NCT03608761 -
Comparison Between Rebamipide 2% Versus Autologous Serum
|
Phase 4 | |
Active, not recruiting |
NCT04793646 -
N-acetylcysteine for Primary Sjögren's Syndrome
|
N/A |